CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Ontario Long Term Care Association

Ontario Long Term Care Association is a Markham, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Global Clinical Trials

Global Clinical Trials is a Princeton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AssistMed

AssistMed is a Beverly Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

FORME

At Forme, we specialize in designing and manufacturing innovative and high-quality health and wellness products. Our extensive range includes sports nutrition, weight loss supplements, and vitamins to support overall wellbeing. We are dedicated to prov...

PTPN

PTPN is a Calabasas, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.